Skip to content

Study on the diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma by conventional ultrasonography combined with lymphatic contrast-enhanced ultrasound

Study on the diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma by conventional ultrasonography combined with lymphatic contrast-enhanced ultrasound

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070109
Enrollment
Unknown
Registered
2023-04-03
Start date
2023-04-03
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papillary thyroid carcinoma

Interventions

Gold Standard:The results of cervical lymph node biopsy and surgical pathology were taken as the gold standard.
Index test:Conventional ultrasound alone, conventional ultrasound combined with lymphatic contrast-enhanced ultrasound The accuracy, sensitivity, specificity, positive predictive value, negative predi

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with papillary thyroid carcinoma who are going to be operated in our hospital. Patients who are over 18 years old. Patients who will sign the informed consent form.

Exclusion criteria

Exclusion criteria: Pregnancy or lactation. Anaphylaxis to contrast agent for ultrasound. History of cervical surgery or radiotherapy. Cervical lymph node metastasis, lymphoma and tuberculous lymphadenitis confirmed by pathological results.

Design outcomes

Primary

MeasureTime frame
accuracy;sensitivity;specificity;positive predictive value;negative predictive value;area under the ROC curve;

Secondary

MeasureTime frame
Comparison of the detection rate of cervical metastatic lymph nodes between the two diagnostic models;

Countries

China

Contacts

Public ContactJinghua Liu

Peking University First Hospital

liujiinghua9485@126.com18811108835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026